Navigation Links
Ovarian cancer's specific scent detected by dogs
Date:6/26/2008

Los Angeles, London, New Delhi, and Singapore (June 26, 2008) Ground-breaking research in the June issue of Integrative Cancer Therapies published by SAGE explored whether ovarian cancer has a scent different from other cancers and whether working dogs could be taught to distinguish it in its different stages.

Ovarian cancer has a high mortality rate, primarily due to late diagnosis. Recent studies have shown that dogs have successfully detected cancer through scent, however, it's not clear whether they're responding to the cancer itself or odors associated with cancer.

The researchers, led by Gyrgy Horvath MD, PhD, from the University Hospital in Gteborg, Sweden, along with colleagues at Working Dog Clubs in Sweden and Hungary, trained dogs to distinguish different types and grades of ovarian cancer, including borderline tumors. They found that the odor of ovarian cancer does seem to differ from those of other gynecological malignancies, such as cervical, or endometrial cancers, suggesting that a particular, distinguishable scent is associated with ovarian cancer. They additionally found that early-stage and low grade ovarian cancers emit the same scent as advanced tumors.

"Our study strongly suggests that the most common ovarian carcinomas are characterized by a single specific odor detectable by trained dogs," write the authors in the article. "And while we do not believe that dogs should be used in clinical practice, because they may be influenced during their work, leading to changes in the accuracy rates, still, under controlled circumstances, they may be used in experiments to further explore this very interesting new property of malignancies."

Adds Keith I. Block, MD, editor-in-chief of Integrative Cancer Therapies, "I believe there is great value in this study, which adds to the growing body of research suggesting the diagnostic skills of these specially trained dogs. Their ability to detect specific odors a
'/>"/>

Contact: Jim Gilden
media.relations@sagepub.com
SAGE Publications
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Cranberry Could Juice Up Ovarian Cancer Treatment
2. New Ovarian Cancer Drug Trial Under Way
3. Pelvic Exams Can Help Spot Ovarian Cancer
4. Study fuels debate over whether exercise and body size influence ovarian cancer risk
5. Experimental drug boosts survival in recurrent ovarian cancer
6. New Ovarian Cancer Biomarker Research Act Introduced
7. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
8. More Fiber, Less Fat Help Prevent Ovarian Cancer
9. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
10. The Silent Killer, Ovarian Cancer on Your Cancer Today (TM)
11. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ewswire/ -- The Pew Charitable Trusts announced to...emical and food safety programs, in its Health &am...ormerly deputy staff director and general counsel ...Works, brings nearly 25 years of experience in env..., , "We are excited to be joined by such an expe...
(Date:1/8/2009)...rstCall/ -- Cephalon, Inc . (Nasdaq: CEPH ) tod...man and CEO will present at the J.P. Morgan Healt...n San Francisco, CA at approximately 4:00 p.m. Pac...will be webcast live on the investor relations sec... will be archived for one week following the broad...
(Date:1/8/2009)...e-FirstCall/ -- Heska Corporation (Nasdaq: HSKA ...hat: Heska Corporation Invites You to Join Its...arnings Conference Call on the Web, When: ...Where: www.heska.com (click on the Q4 and Year-...front page of this website)., How: Live...
(Date:1/8/2009)...wire/ -- St. Jude Children,s Research,Hospital(R)...Cup Runner-Up,Camilo Villegas has increased his c... match Singh,s donation of $5,000 to St. Jude for ...s for St. Jude is a powerful program that,has uni...sing LPGA star Morgan,Pressel, along with the Gol...
Breaking Medicine News(10 mins):Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4
...o latest research , sudden emotional stress can re...s that mimics a classic heart attack.// Stress ca...sive heart attack. According to the researchers, p...rge in adrenalin and other stress hormones that te...
...ndings of a recent study researchers say , cancer ...us thrombosis, // or blood clots in the legs or lu...o 70, who had a blood clot in their legs or lungs....he presence of distant metastases, and carrier sta...
...world congress for diabetes begins in Chennai toda...betes and its complications //and over 1000 doctor...untries across the world. The world congress for...very three years, since the time of its inception ...
...tion therapy is used to treat deep vein thrombosis...is or arms. Researchers say several new studies sh...plify anticoagulation therapy.// In the first stu...hrombosis) patients and compared the effectiveness...
Other Medicine News:
(Date:1/7/2009)...PRNewswire/ -- ImQuest Life Sciences announced tod... to the Food and Drug Administration to initiate h...e HIV inhibitor IQP-0410. ImQuest anticipates init...of 2009. IQP-0410 is a novel small molecule inhibi... reverse transcriptase inhibitor (NNRTI). The comp...
(Date:1/7/2009)...uary 7 Circassia Ltd, a specialty,...critical care, today,announced that following suc...s ToleroMune(R) anti-allergy technology, the compa...rther phase II clinical trial in cat allergy. The,... 120 patients with confirmed,cat allergies, and a...
(Date:1/6/2009)...RNewswire/ -- In recent controlled studies conduct..., scientists found that the patented ingredient in...y proven ingredient to increase levels of nitric o...trate/nitrate (NOx) in human subjects. , , Nitr...ease in blood flow to the skeletal muscles. This ...
(Date:1/6/2009)... Cequent Pharmaceuticals, a pionee...RNAi-based treatments to prevent and treat human d...mpleted a successful toxicology study of its candi...peutic targeting the primary oncogene (beta-cateni.... FAP is an inherited gastrointestinal disease tha...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 23563 1Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 23563 2Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 23563 3China Medicine Releases White Paper on Developing Recombinant Aflatoxin Detoxifizyme 23558 1China Medicine Releases White Paper on Developing Recombinant Aflatoxin Detoxifizyme 23558 2Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 1Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 2Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 3Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 1Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 2Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 3Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 4
...ETROIT, April 16, 2007 /PRNewswire/ -- Karmanos Ca... on two research,studies investigating racial disp... American Association of Cancer Research,annual me...h endometrial or ovarian cancer, on,average, live ...ed,by Veronica Schimp, D.O., assistant professor o...
...nespimycin Shown to Have No Effect on QTc Interval...Kosan,Biosciences Incorporated today presented saf...its lead Hsp90 inhibitor,tanespimycin (KOS-953). ...nts was conducted in four Phase 1 trials of tanesp... in more than 85,patients. Tanespimycin was found ...
Other Medicine Technology:Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 2Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 3Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 2Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 3Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 4
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: